Drug Patents owned by Sunovion Resp

1. Drug name - LONHALA MAGNAIR KIT

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8511581 SUNOVION RESP Fluid droplet production apparatus and method Nov, 2023

(1 year, 1 month from now)

US7458372 SUNOVION RESP Inhalation therapy device Nov, 2024

(2 years from now)

US7931212 SUNOVION RESP Fluid droplet production apparatus and method Nov, 2025

(3 years from now)

US9265900 SUNOVION RESP Disposable ampoule for an aerosol generating device Dec, 2028

(6 years from now)

US10940110 SUNOVION RESP Method and system for the treatment of chronic COPD with nebulized anticholinergic administrations Feb, 2029

(6 years from now)

US9789270 SUNOVION RESP Inhalation therapy device comprising an ampoule for storing a medicament to be nebulized Oct, 2030

(8 years from now)

US9168556 SUNOVION RESP Membrane nebulizer and method for welding a membrane to a carrier during the production of a membrane nebulizer Sep, 2032

(9 years from now)

US9604018 SUNOVION RESP Aerosol therapy device May, 2033

(10 years from now)

US10376661 SUNOVION RESP Opening element for opening an ampoule in an aerosol generation device and aerosol generation device comprising the opening element Sep, 2035

(12 years from now)

US10688518 SUNOVION RESP Method of manufacturing a vibratable head for an aerosol generator and vibratable head for an aerosol generator Nov, 2036

(14 years from now)

US10744277 SUNOVION RESP Aerosol delivery device and method of operating the aerosol delivery device Dec, 2036

(14 years from now)

Drugs and Companies using GLYCOPYRROLATE ingredient

Treatment: Long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (copd); A method of using an aerosol delivery device to aerosolize glycopyrrolate for the treatment of chronic obstructive pulmonary disease (copd)

Dosage: SOLUTION;INHALATION

More Information on Dosage
Strength Dosage Availability
25MCG/ML SOLUTION;INHALATION Prescription

availability in other generic markets.

Click on the highlighted region to filter.